<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Regeneron Announces Positive Phase II Results for Evinacumab
Image Overlay - Regeneron Announces Positive Phase II Results for Evinacumab

Regeneron Announces Positive Phase II Results for Evinacumab

Regeneron Announces Positive Phase II Results for Evinacumab

In a trial evaluating patients with homozygous familial hypercholesterolemia, a genetically inherited form of increased LDL cholesterol, Regeneron’s drug showed a 49% decrease in LDL levels, compared with a 2% decrease for placebo. Yourway is dedicated to helping support clinical trials like this for rare disease patients.

Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Global Clinical Supplies Group (GCSG)

October 14-16, 2025
Hungary, Budapest

Clinical Outsourcing Group (COG)

October 21-22, 2025
Burlingame, California

Media

Articles

Keeping trials on track: Prioritizing communication in decentralized trials

Open chat
Come chat with us!
Hello! How can I help you?